U. Latza et al., THE HUMAN OX40 HOMOLOG - CDNA STRUCTURE, EXPRESSION AND CHROMOSOMAL ASSIGNMENT OF THE ACT35 ANTIGEN, European Journal of Immunology, 24(3), 1994, pp. 677-683
Tissue distribution and expression on mitogen and virally stimulated l
ymphocytes render the ACT35 molecule a human lymphocyte activation ant
igen which as yet could not be clustered. Expression cloning of the AC
T35 antigen from a pCDM8 library of the HUT-102 cell line revealed str
ong homology of the cDNA and its encoded protein sequence with the for
merly described rat OX40 antigen. The 1.4-kb nucleotide sequence and t
he deduced 277-amino acid sequence of the single transmembrane protein
were 65% and 63% identical, in human and in rat, respectively. Conser
vation included one N-linked glycosylation site and one protein kinase
C phosphorylation site. When expressed in COS-1 cells, the cDNA prese
nted properties comparable to the native ACT35 antigen and the rat OX4
0 molecule (relative molecular mass 48 000). Thus, the ACT35 protein c
orresponds to the hitherto unknown human OX40 antigen and is, therefor
e, another member of the tumor necrosis factor/nerve growth factor rec
eptor (TNFR/NGFR) family. After applying fluorescence in situ hybridiz
ation, the human ACT35/OX40 gene could be mapped to chromosome band 1p
36 and is, thus, linked to the genes for TNFR II and CD30.